$EVMN

$5.16 +$0.03 (0.58%) Close

$EVMN Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 36.3M shares outstanding

Who owns EVMN?

By type of holder

Institutions 95.3% Insiders 4.7% Everyone else 0.0%

Concentration Top 10 holders own 100.0%

EQT Fund Management S.a r.l. 14.6% · LSP 7 Cooperatieve U.A. 14.6%

Institutional ownership

95.3%

-0.0 pts vs last qtr

Institutional holders

104

+20 vs last qtr

Net shares bought

−3.8K

by institutions in Q2 2026

New / sold out

40 / 20

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Point72 Asset Management, L.P. +1.4M
Vestal Point Capital, LP NEW +1.0M

Biggest sellers in Q2 2026

MPM Bioimpact LLC SOLD OUT −1.5M
SymBiosis Capital Partners, LLC SOLD OUT −1.3M

Who is planning to sell?

Notices of proposed sale, last 12 months

$2.55M

6 notices from 6 people

Shares covered

111.6K

0.31% of the company

Arranged in advance

100%

of the value is under a 10b5-1 plan

Under a 10b5-1 plan No plan

Largest proposed sellers

Kyle Carver Officer 10b5-1 $599K
Luis Pena Director 10b5-1 $563K

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2024–FY2025

+306.9%

+306.86% a year

Each share's claim on the business

−75.4%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $7.58M

over 2 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years0% 1–3 years0% Under 1 year100%

Quarterly turnover

25.3%

of institutional shares changed hands

Top 10 managers, median time held

2 quarters

Super Investors

Investment managers reporting EVMN on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
EF EQT Fund Management S.a r.l.	5.3M	14.57%	+358.7K (+7.3%)	Q4 '25	8.2%
Shares held by quarter Peak holding5.3M (Q2'26) Change over 8 quarters+5.3M Share of the company14.570% EQT Fund Management S.a r.l.'s full portfolio →
RC Ra Capital Management, L.P. 13D · 9.7%	3.5M	9.63%	Unchanged	Q4 '25	0.4%
Shares held by quarter Peak holding3.5M (Q1'26) Change over 8 quarters+3.5M Share of the company9.630% Disclosed stake13D · 9.7% Ra Capital Management, L.P.'s full portfolio →

EQT Fund Management S.a r.l.

5.3M

% of company

14.57%

Change vs last qtr

+358.7K (+7.3%)

Held since

Q4 '25

Ra Capital Management, L.P.

13D · 9.7%

3.5M

% of company

9.63%

Change vs last qtr

Unchanged

Held since

Q4 '25

28 more super investors behind a free account

See every manager holding Evommune, Inc., how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting EVMN on Form N-PORT; together they hold 17.4% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
EH Eventide Healthcare & Life Sciences Fund Mutual Fund Series Trust	$12.5M	940.1K	2.59%	0.70%	June 30, 2026
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$9.82M	739.1K	2.04%	0.00%	June 30, 2026

Eventide Healthcare & Life Sciences Fund

Mutual Fund Series Trust

Position value

$12.5M

% of company

2.59%

% of the fund

0.70%

As of

June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$9.82M

% of company

2.04%

% of the fund

0.00%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding Evommune, Inc. and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
L7 LSP 7 Cooperatieve U.A. 5%+ holder 13D · 14.7%	5.3M	14.57%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company14.570% Disclosed stake13D · 14.7% View the 13D/G filing →
VW Verduyn-van Weegen Felice Isabel Insider	5.3M	14.57%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company14.570% Verduyn-van Weegen Felice Isabel's insider activity →

LSP 7 Cooperatieve U.A.

5%+ holder13D · 14.7%

5.3M

% of company

14.57%

Change vs last qtr

—

Held since

—

Verduyn-van Weegen Felice Isabel

Insider

5.3M

% of company

14.57%

Change vs last qtr

—

Held since

—

12 more holders behind a free account

See every insider and 5%+ holder of Evommune, Inc..

Comments